BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21630670)

  • 1. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.
    Shin HC; Alani AW; Cho H; Bae Y; Kolesar JM; Kwon GS
    Mol Pharm; 2011 Aug; 8(4):1257-65. PubMed ID: 21630670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.
    Shin DH; Kwon GS
    Int J Pharm; 2017 Feb; 518(1-2):307-311. PubMed ID: 28062368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
    Shin HC; Cho H; Lai TC; Kozak KR; Kolesar JM; Kwon GS
    J Control Release; 2012 Oct; 163(1):93-9. PubMed ID: 22549011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.
    Cho H; Kwon GS
    J Drug Target; 2014 Aug; 22(7):669-77. PubMed ID: 24964052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligo(lactic acid)n-Paclitaxel Prodrugs for Poly(ethylene glycol)-block-poly(lactic acid) Micelles: Loading, Release, and Backbiting Conversion for Anticancer Activity.
    Tam YT; Gao J; Kwon GS
    J Am Chem Soc; 2016 Jul; 138(28):8674-7. PubMed ID: 27374999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-b-PLA micelles and PLGA-b-PEG-b-PLGA sol-gels for drug delivery.
    Cho H; Gao J; Kwon GS
    J Control Release; 2016 Oct; 240():191-201. PubMed ID: 26699425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl and oligo(lactic acid) prodrugs for PEG-b-PLA and PEG-b-PCL nano-assemblies for injection.
    Repp L; Rasoulianboroujeni M; Lee HJ; Kwon GS
    J Control Release; 2021 Feb; 330():1004-1015. PubMed ID: 33166607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-drug delivery to tumor cells via micellar nanocarriers.
    Katragadda U; Teng Q; Rayaprolu BM; Chandran T; Tan C
    Int J Pharm; 2011 Oct; 419(1-2):281-6. PubMed ID: 21820041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs.
    Shin HC; Alani AW; Rao DA; Rockich NC; Kwon GS
    J Control Release; 2009 Dec; 140(3):294-300. PubMed ID: 19409432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-clinical evaluation of a themosensitive gel containing epothilone B and mTOR/Hsp90 targeted agents in an ovarian tumor model.
    Shin DH; Kwon GS
    J Control Release; 2017 Dec; 268():176-183. PubMed ID: 29056443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric micelles for neoadjuvant cancer therapy and tumor-primed optical imaging.
    Cho H; Kwon GS
    ACS Nano; 2011 Nov; 5(11):8721-9. PubMed ID: 21999531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrotropic polymeric micelles for enhanced paclitaxel solubility: in vitro and in vivo characterization.
    Lee SC; Huh KM; Lee J; Cho YW; Galinsky RE; Park K
    Biomacromolecules; 2007 Jan; 8(1):202-8. PubMed ID: 17206808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro.
    Wei Y; Xu S; Wang F; Zou A; Zhang S; Xiong Y; Cao S; Zhang Q; Wang Y; Jiang X
    J Pharm Sci; 2015 Jan; 104(1):165-77. PubMed ID: 25421492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.
    Xiong MP; Yáñez JA; Kwon GS; Davies NM; Forrest ML
    J Pharm Sci; 2009 Apr; 98(4):1577-86. PubMed ID: 18752263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
    J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.
    Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS
    J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.